Anti-CD44 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22102; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-CD44 Polyclonal Antibody: A Powerful Tool for Targeting Cancer and Inflammation
Anti-CD44 polyclonal antibody is a highly specific and versatile tool for researchers in the field of biotechnology. This antibody is derived from animal sources and has been extensively tested for its efficacy and purity. Its unique ability to target CD44, a key protein involved in cancer and inflammation, makes it a valuable addition to any biotech laboratory.
CD44 is a transmembrane glycoprotein that plays a crucial role in cell adhesion, migration, and signaling. It is overexpressed in various types of cancer and is associated with tumor growth, invasion, and metastasis. CD44 is also involved in inflammatory processes, such as leukocyte recruitment and activation. By targeting CD44, the anti-CD44 polyclonal antibody can inhibit these processes and potentially provide therapeutic benefits.
The primary application of anti-CD44 polyclonal antibody is in cancer research. It can be used to study the role of CD44 in tumor development and progression, as well as to identify potential therapeutic targets. This antibody can also be used in inflammation research to investigate the role of CD44 in immune responses and disease pathogenesis. Additionally, it can be used in diagnostic assays to detect CD44 expression levels in patient samples.
Anti-CD44 polyclonal antibody has been successfully used in various experimental settings. In one study, it was used to inhibit the growth and metastasis of breast cancer cells by targeting CD44. In another study, it was used to block the recruitment of inflammatory cells in a mouse model of arthritis, resulting in reduced joint inflammation. These examples demonstrate the potential of this antibody in both cancer and inflammation research.
Some natural keywords to integrate into the content are: CD44, polyclonal antibody, cancer, inflammation, biotechnology, therapeutic, tumor, immune response, diagnostic, research, experimental, animal sources, efficacy, purity, glycoprotein, cell adhesion, migration, signaling, overexpression, leukocyte recruitment, activation, therapeutic targets, disease pathogenesis, diagnostic assays, breast cancer, metastasis, mouse model, arthritis.
Conclusion:
In summary, the anti-CD44 polyclonal antibody is a powerful tool for targeting cancer and inflammation. Its ability to specifically bind to CD44 makes it a valuable asset in various research applications. With its proven efficacy and purity, this antibody is a reliable choice for researchers in the biotech industry. Add it to your laboratory arsenal today and advance your research on CD44 and its role in disease.
ProteoGenix catalogue number ARO-A22102. For research use only.
Target: CD44 antigen isoform X1; CD44; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| CD44 antigen isoform X1; CD44 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
